StreetAlpha.app
Home › Stocks › NEO

Neogenomics Inc (NEO)

Healthcare
$14.82
▼ −1.79%
LAST CLOSE · NOV 20

NeoGenomics provides cancer diagnostic testing and pathology interpretation services for doctors, hospitals and drug developers. It last closed at $14.82 on Nov 20, down 1.79% on the day. The next earnings report for NEO is expected around Tue, Jan 26, 2027. Over its last 8 reports the stock moved an average of 11.1% the session after earnings. Over the last 12 months NEO insiders bought $0 of stock on the open market and sold $968K, according to SEC Form 4 filings.

AI Auto Pilots
Is NEO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold NEO.

Key Stats

Last 12 months
Results
Revenue
$787.8M
+11.1% vs a year ago
Net income
−$32.3M
−4.1% margin
Free cash flow
−$28.6M
−3.6% margin
Gross margin
44.8%
$352.7M gross profit
Valuation
Market cap
$1.9B
129.4M shares
P/E
–
Price to sales
2.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$139.3M
At Sep 30
Debt
$374.7M
At Sep 30
Shareholder equity
$800.6M
Shares outstanding
129.4M
At Oct 23
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $484.3M$484.3MFY2021FY2022: $509.7M$509.7MFY2022FY2023: $591.6M$591.6MFY2023FY2024: $660.6M$660.6MFY2024FY2025: $727.3M$727.3MFY2025

From NEO's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 28). Last 12 months adds up the four latest quarters.

Next report
Jan 26
Estimated date · Time not announced
Reported EPS
—
Quarter ended Sep 2026
Year ago EPS
—
Same quarter last year
Revenue
$209.3M
+11.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Not enough quarters on file yet.
Revenue by quarter
Dec 2024: $172.0MDec '24Mar 2025: $168.0MMar '25Jun 2025: $181.3MJun '25Sep 2025: $187.8MSep '25Dec 2025: $190.2MDec '25Mar 2026: $186.7MMar '26Jun 2026: $201.7MJun '26Sep 2026: $209.3MSep '26Latest $209.3M
How NEO moved after its last 8 reports
Average move the session after a report ±11.1%
Oct 5, 2026After the close−13.7%
Jul 28, 2026After the close+14.0%
Apr 28, 2026After the close−0.7%
Feb 17, 2026Time not announced+0.5%
Jan 12, 2026Time not announced−5.1%
Oct 28, 2025Time not announced−2.4%
Jul 29, 2025Time not announced−18.7%
Apr 29, 2025Time not announced−34.0%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on NEOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Analyst Ratings & Price Targets

Analyst Ratings →
AI Starter and AI Pro
Full analyst coverage on NEO
  • Every upgrade, downgrade and initiation as it happens
  • Every price target change, raised or cut
  • Consensus rating with the average, high and low targets
  • Each firm's full rating history on NEO

Technical Analysis

NEO · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend, nearing oversold

The stock is 12% below its 20 day and 17% below its 50 day average. It is 12% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 34), near oversold. The nearest support is the Pivot S1 at $14.59, and the nearest resistance the Pivot at $14.86.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityNormal, 5.5%/day
Key levels
$20.1552 week high+36.0%
$17.3250 day average+16.9%
$16.59100 day average+11.9%
$16.5420 day average+11.6%
$15.10Pivot R1+1.9%
$15.04Swing high (Jul 17)+1.5%
$14.86Pivot+0.3%
$14.82Last close
$14.59Pivot S1−1.6%
$13.81Swing low (Jul 8)−6.8%
$13.07200 day average−11.8%
$7.0752 week low−52.3%
Indicators
RSI (14)34.25Weak, oversold below 30Neutral
MACD-0.55Below its signal lineBearish
Stochastic9.2Near the bottom of its rangeOversold
ADX (14)19.6No clear trend
Williams %R-93.8Oversold below −80, overbought above −20Oversold
CCI (20)-154.5Oversold below −100, overbought above 100Oversold
Rate of change−12.0%Change over 10 sessionsBearish
ATR (14)$0.81Typical daily range, 5.5% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Above
What happened before, for NEO

What happened before

See how NEO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow NEO usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How NEO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2012.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for NEOHow many large options trades hit NEO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

NEO Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ●150 buying vs 132 selling
  • ▼Held by funds -1.9 pts
  • ▲Funds holding +29
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding297268+10.8%
In funds' top 1045−20.0%
Held by funds110.2%112.1%−1.9 pts
New / increased62 / 8855 / 94+0.7%
Reduced / sold out100 / 3262 / 42+26.9%
Put/call ratio0.000.00–
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See NEO institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

NEO Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$968K5 sales · 4 insiders
67% of the selling was under pre-arranged trading plans.
2026-01 sold $277K2026-06 sold $119K2026-08 sold $321KDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Aug 4Greg D AunanChief Accounting OfficerSale20,000$16.07$321K
Jun 15Lynn A. TetraultDirectorSale plan5,307$11.10$59K
Jun 9Lynn A. TetraultDirectorSale plan5,307$11.29$60K
Jan 20Warren StonePres & COOSale plan22,128$12.50$277K
Nov 25, 2025Alicia C OlivoEVP, GC & Business DevelopmentSale plan20,916$12.00$251K
Oct 16, 2025Alicia C OlivoEVP, GC & Business DevelopmentSale plan4,918$10.00$49K
Every insider buy and sale for NEO over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See NEO insider trades →

From SEC Form 4 filings by NEO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether NEO is in one of them and how their past NEO trades turned out.

NEO in the AI portfolios
Loading…

NEO News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered NEO in an article yet. Here's the latest on the wider market.

NEO in the news

NEO Congress Trades

All congress trades →
Trades, 12 months
1
Buys
1
100%
Sells
0
0%
People
1
Last filed Sep 10
Who traded NEO · since 2019
Latest 5 filings of 7
$1K – $15KTraded Aug 7, 2026Filed Sep 10, 2026
$1K – $15KTraded May 7, 2025Filed Jun 6, 2025
$1K – $15KTraded Mar 30, 2022Filed Apr 25, 2022
$15K – $50KTraded Dec 30, 2021Filed Jan 8, 2022
$1K – $15KTraded Nov 9, 2021Filed Nov 14, 2021
PersonTypeAmountTradedFiledDelay
Gilbert CisnerosD · CABuy$1K – $15KAug 7, 2026Sep 10, 202634 d
Gilbert CisnerosD · CABuy$1K – $15KMay 7, 2025Jun 6, 202530 d
Dwight EvansD · PASell$1K – $15KMar 30, 2022Apr 25, 202226 d
Deborah k. RossD · NCBuy$15K – $50KDec 30, 2021Jan 8, 20229 d
Bob GibbsR · OHSell$1K – $15KNov 9, 2021Nov 14, 20215 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data

About Neogenomics

NeoGenomics provides cancer diagnostic testing and related consulting services from its headquarters in Fort Myers, Florida. Its laboratories run tests such as cytogenetics, flow cytometry, molecular and sequencing panels, and residual disease testing, and its pathologists and molecular experts interpret the results. Its customers include community pathology and oncology practices, hospitals, reference labs, academic centers and pharmaceutical companies. The company also offers research support and data licensing services to drug developers.

Headquarters
Fort Myers, FL
Founded
2002